InvestorsHub Logo
Followers 10
Posts 1254
Boards Moderated 0
Alias Born 07/20/2020

Re: None

Thursday, 04/04/2024 1:56:59 PM

Thursday, April 04, 2024 1:56:59 PM

Post# of 651520
NRXP -MC $50m -Phase 3 results imminent for their bipolar depression drug expected this month and another Phase 3 results from their chronic back pain trial also expected in the coming weeks . With positive results this low floater going to explode toward $20 currently trading at $5.20 .Check out their presentation below for more informations

Presentation
https://www.nrxpharma.com/wp-content/uploads/NRx-Corporate-Presentation.pdf
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.